Managers / Q1 2026
Alphabet Inc.
CIK 0001652044 · 1600 AMPHITHEATRE PARKWAY, MOUNTAIN VIEW, CA, 94043 · 650-253-0000
Summary
Alphabet Inc. reported $4.0B in U.S.-listed holdings across 27 positions for Q1 2026.
The portfolio is heavily concentrated: CME alone accounts for 25.6% of reported value.
Compared with Q4 2025, the fund opened 3 new positions and exited 6.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 90.9% · $3.7B
- ADR · 9.1% · $364M
Quarter-over-Quarter Changes full breakdown →
vs Q4 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| CMECME GROUP INC | NEW | +3.48M | 3.48M | +$1.0B | $1.0B |
| PAYPPAYPAY CORP | NEW | +3.13M | 3.13M | +$67M | $67M |
| LIFEETHOS TECHNOLOGIES INC | NEW | +3.77M | 3.77M | +$42M | $42M |
| DC4DEXCOM INC | SOLD OUT | −1.04M | 0 | −$69M | $0 |
| WGSGENEDX HOLDINGS CORP | SOLD OUT | −22.7K | 0 | −$3M | $0 |
| EXKEXACT SCIENCES CORP | SOLD OUT | −23.2K | 0 | −$2M | $0 |
| QUINCE THERAPEUTICS INC | SOLD OUT | −189.1K | 0 | −$633,559 | $0 |
| FULCFULCRUM THERAPEUTICS INC | SOLD OUT | −14.3K | 0 | −$161,303 | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2026
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $4.0B | 27 | May 8, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $2.6B | 32 | Feb 13, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $2.4B | 40 | Nov 7, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $2.1B | 39 | Aug 1, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $1.6B | 44 | May 2, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $1.7B | 44 | Feb 7, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $1.8B | 46 | Nov 8, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $2.0B | 46 | Aug 2, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $2.5B | 47 | May 3, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $2.2B | 48 | Feb 9, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $1.6B | 51 | Nov 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $1.9B | 56 | Aug 4, 2023 | 13F-HR | changes · EDGAR ↗ |
Other Included Managers
This filing reports holdings on behalf of 3 additional managers.
- GV Management Company, L.L.C.028-22704
- Google LLC028-22705
- CapitalG II LP028-22706
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.